Skip to Main Content

Paper Details

Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression.
Nat Commun
14
2022
aurora, aurora kinase, aurora kinases, cancer, cancer cell lines, early-stage lung adenocarcinoma, esLUAD, gene signature, gene signatures, invasive, lung adenocarcinoma, lung cancer, murine, patients, tumor, tumors
Author NameAffiliation
Seungyeul YooIcahn School of Medicine at Mount Sinai
Seungyeul Yoo
Seungyeul YooIcahn Institute for Data Science and Genomic Technology
Nasser K AltorkiWeill Cornell Medicine-New York Presbyterian Hospital
Eunjee LeeIcahn School of Medicine at Mount Sinai
Eunjee Lee
Eunjee LeeIcahn Institute for Data Science and Genomic Technology
Eunjee LeeIcahn School of Medicine at Mount Sinai
Eunjee LeeIcahn Institute for Data Science and Genomic Technology
Eunjee Lee
Eric E SchadtIcahn School of Medicine at Mount Sinai
Eric E SchadtIcahn School of Medicine at Mount Sinai
Eric E SchadtTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Eric E Schadt
Eric E SchadtIcahn Institute for Data Science and Genomic Technology
Eric E SchadtIcahn Institute for Data Science and Genomic Technology
Eric E Schadt
Eric E SchadtTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Pierre P MassionVanderbilt University Medical Center
Pierre P MassionVanderbilt University Medical Center
Alain C Borczuk
Jun ZhuIcahn School of Medicine at Mount Sinai
Jun ZhuIcahn Institute for Data Science and Genomic Technology
Jun Zhu
Jun ZhuTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 25

Datasets

Release 1.2